Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Long Term Debt 2012–2025
Coherus Biosciences Inc. annual long term debt history from 2019 to 2019. Long term debt refers to financial obligations that are due more than one year in the future.
- Coherus Biosciences Inc. long term debt as of December 31, 2019: 73.7M.
- Coherus Biosciences Inc. long term debt for 2019 were 73.7M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Coherus Biosciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2019 | $74 |
Coherus Biosciences Inc. Long Term Debt — FAQ
Coherus Biosciences Inc. (CHRS) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CHRS's long term debt history?
The chart and table above show Coherus Biosciences Inc.'s long term debt by year and by quarter, including the growth rate.